Showing results (591-600 of 601) with videos related to
Sort By:
Pageof 61
Journal of Cellular and Molecular Medicine|October 30, 2020
NR4A1 counteracts JNK activation incurred by ER stress or ROS in pancreatic β-cells for protectionZe-Qing Pu, Dong Liu, Hanse Pablick Patherny Lobo Mouguegue, et al.Genomics|March 7, 2021
Dipylidium caninum draft genome - a new resource for comparative genomic and genetic explorations of flatwormsGuo-Hua Liu, Pasi K Korhonen, Neil D Young, et al.Emerging Microbes & Infections|November 26, 2021
Emergence, prevalence, and evolution of H5N8 avian influenza viruses in central China, 2020Xiang Li, Xinru Lv, Yi Li, et al.Hepatobiliary Surgery and Nutrition|January 10, 2022
A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombusWan Yee Lau, Kang Wang, Xiu-Ping Zhang, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 5, 2025
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort studyJin-Hong Chen, Lu Lu, Xiao-Yun Zhang, et al.Hepatology International|April 8, 2020
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide studyZhen-Hua Chen, Xiu-Ping Zhang, Yu-Gang Lu, et al.Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2025
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapyKong-Ying Lin, Hong-Zhi Liu, Jian-Wei Liu, et al.Journal of Clinical and Translational Hepatology|January 1, 2024
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)Han Wang, Jun Chen, Xin Zhang, et al.Liver Cancer|October 16, 2018
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)Jian Zhou, Hui-Chuan Sun, Zheng Wang, et al.Pageof 61